These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2517439)

  • 41. Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis.
    Gutterman JU; Hersh EM; Mavligit GM; Freireich EJ; Rossen RD; Butler WT; McCredie KB; Bodey GP; Rodriguez V
    Natl Cancer Inst Monogr; 1973 Jun; 37():153-65. PubMed ID: 4576706
    [No Abstract]   [Full Text] [Related]  

  • 42. [Transfusion complications caused by rarely occurring non-D antibodies].
    Orv Hetil; 1983 Feb; 124(9):545. PubMed ID: 6405339
    [No Abstract]   [Full Text] [Related]  

  • 43. Leukaemia in Nigerians. I. The acute leukaemias.
    Essien EM
    Afr J Med Sci; 1972 Apr; 3(2):117-30. PubMed ID: 4623911
    [No Abstract]   [Full Text] [Related]  

  • 44. Absence of graft-versus-leukemia effect of standard hemotherapy in patients with acute myeloblastic leukemia.
    Lopez J; Fernandez-Villalta MJ; Gomez-Reino F; Fernandez-Rañada JM
    Transfusion; 1990 Feb; 30(2):191-2. PubMed ID: 2305448
    [No Abstract]   [Full Text] [Related]  

  • 45. Apparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia.
    Tucker J; Murphy MF; Gregory WM; Lim J; Rohatiner AZ; Waters AH; Lister TA
    Br J Haematol; 1989 Dec; 73(4):572-4. PubMed ID: 2611147
    [No Abstract]   [Full Text] [Related]  

  • 46. [Behavior of anti-Gma antibodies and clinical observations in patients after transfused Gm(a+) blood].
    Górska B; Maj S
    Pol Arch Med Wewn; 1967; 39(1):99-102. PubMed ID: 5299066
    [No Abstract]   [Full Text] [Related]  

  • 47. Caprylate-dependent auto-anti-e.
    Dube VE; Zoes C; Adesman P
    Vox Sang; 1977 Dec; 33(6):359-63. PubMed ID: 412322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Qualitative and quantitative study of a DVI variant with anti-D in the serum].
    Puig N; Carbonell F; Arriaga F; Lorenzo I; Montoro JA; Soler A; Pérez-Castellanos T; Miravalls C; Marty ML
    Sangre (Barc); 1986; 31(3):335-9. PubMed ID: 3092375
    [No Abstract]   [Full Text] [Related]  

  • 49. Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient.
    Markiewicz M; Wojnar J; Giebel S; Wieczorkiewicz A; Wylezoł I; Hołowiecki J
    Bone Marrow Transplant; 2006 Feb; 37(4):433-4. PubMed ID: 16400335
    [No Abstract]   [Full Text] [Related]  

  • 50. Complement dependent cytotoxic autoantibodies in patients with acute leukaemia following fibrinolytic therapy by protease 1 of aspergillus oryzae.
    Thornes RD; Kee JL; Devlin JG; MacDonell JD
    Ir J Med Sci; 1970 Mar; 3(3):107-14. PubMed ID: 5268985
    [No Abstract]   [Full Text] [Related]  

  • 51. Acquired auto-anti D in a patient with myelodysplastic syndrome.
    Yermiahu T; Dvilansky A; Avinoam I; Benharroch D
    Sangre (Barc); 1991 Feb; 36(1):47-9. PubMed ID: 1906640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies in systemic lupus erythematosus.
    McCurdy DK; Bick M; Gatti RA; Naeim F
    Dis Markers; 1992; 10(1):37-49. PubMed ID: 1358497
    [No Abstract]   [Full Text] [Related]  

  • 53. Weakening of antigen D and development of anti-D in a patient with acute myeloid leukaemia.
    Mujeeb SA; Siddiqui S; Khursheed T; Hashmi MR
    J Pak Med Assoc; 1989 Dec; 39(12):324-5. PubMed ID: 2517439
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.